ICD-9-CM 710.1 is a billable medical code that can be used to indicate a diagnosis on a reimbursement claim, however, 710.1 should only be used for claims with a date of service on or before September 30, 2015. For claims with a date of service on or after October 1, 2015, use an equivalent ICD-10-CM code (or codes).
Calcinosis, Raynaud's phenomenon, esophageal dysmotility, sclerodactyly, and telangiectasia syndrome (disorder)
Crest syndrome
Lipodermatosclerosis
Lung disease with systemic sclerosis
Myopathy due to scleroderma
Myopathy due to systemic sclerosis
Polyneuropathy due to systemic sclerosis
Progressive systemic sclerosis
Scleredema
Scleredema buschkes
Scleroderma
Scleroderma induced by chemical, including drugs
Scleroderma of lung
Scleroderma w glomerulonephritis
Scleroderma w lung involvement
Scleroderma w polyneuropathy
Scleroderma with glomerulonephritis
Scleroderma with glomerulonephritis (gn)
Scleroderma with lung involvement
Scleroderma with polyneuropathy
Systemic sclerosis induced by chemical, including drug
Systemic sclerosis induced by chemical, including drugs
Systemic sclerosis induced by drugs and chemicals
Systemic sclerosis w myopathy
Systemic sclerosis w polyneuropathy
Clinical Information
A chronic disorder marked by hardening and thickening of the skin. Scleroderma can be localized or it can affect the entire body (systemic)
A chronic disorder, possibly autoimmune, marked by excessive production of collagen which results in hardening and thickening of body tissues. The two types of systemic scleroderma, limited cutaneous and diffuse cutaneous are classified with focus on the extent of affected skin. A relationship exists between the extent of skin area affected and degree of internal organ/system involvement. Systemic scleroderma can manifest itself in pulmonary fibrosis, raynaud's syndrome, digestive system telangiectasias, renal hypertension and/or pulmonary hypertension
A chronic multi-system disorder of connective tissue. It is characterized by sclerosis in the skin, the lungs, the heart, the gastrointestinal tract, the kidneys, and the musculoskeletal system. Other important features include diseased small blood vessels and autoantibodies. The disorder is named for its most prominent feature (hard skin), and classified into subsets by the extent of skin thickening: limited scleroderma and diffuse scleroderma
A disease that is marked by hardening and thickening of skin, connective tissue that surrounds other tissues and organs, and blood vessels
A rare, chronic disease characterized by excessive deposits of collagen in the skin or other organs
Chronic hardening and thickening of the skin caused by swelling and thickening of fibrous tissue leading to eventual atrophy of the epidermis; can occur as a localized or a systemic disease
Systemic disorder of the connective tissue; manifested by hardening and thickening of the skin, by abnormalities involving the microvasculature and larger vessels, and by fibrotic degenerative changes in various body organs including the heart, lungs, kidneys, and gastrointestinal tract